Enhanced Recovery After Surgery for Spine Fusion Surgeries in the Elderly (ERAS in Spine)
August 28, 2024 updated by: Aikeremujiang Muheremu, Sixth Affiliated Hospital of Xinjiang Medical University
elderly patients in our hospital who received spinal fusion surgery after the year 2025 will receive ERAS treatment.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aikeremujiang Professor Ai
- Phone Number: +8618810914750
- Email: muheremua@bjmu.edu.cn
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
elderly patients who received spinal fusion surgeries
Description
Inclusion Criteria:
- elderly patients who received spinal fusion surgeries
Exclusion Criteria:
- patients who received non-fusion surgeries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
elderly after spine fusion surgery
patients receive Enhanced recovery after spinal fusion surgery
|
The ERAS program for lumbar fusion surgery will be implemented.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ambulation time
Time Frame: 7 days
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
mean hospital length of stay
Time Frame: one month
|
one month
|
|
cost of hosptial stay
Time Frame: 1 months
|
1 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
August 27, 2024
First Submitted That Met QC Criteria
August 28, 2024
First Posted (Actual)
August 29, 2024
Study Record Updates
Last Update Posted (Actual)
August 29, 2024
Last Update Submitted That Met QC Criteria
August 28, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SixthAHXinjiang
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
will decide before the year 2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.